<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">AAPS PharmSci</journal-id><journal-id journal-id-type="pmc-domain-id">989</journal-id><journal-id journal-id-type="pmc-domain">pharmsci</journal-id><journal-title-group><journal-title xml:lang="en">AAPS PharmSci</journal-title></journal-title-group><issn pub-type="epub">1522-1059</issn><publisher><publisher-name>Springer</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC2750998</article-id><article-id pub-id-type="pmcid-ver">PMC2750998.1</article-id><article-id pub-id-type="pmcaid">2750998</article-id><article-id pub-id-type="pmcaiid">2750998</article-id><article-id pub-id-type="pmid">11741219</article-id><article-id pub-id-type="doi">10.1208/ps020103</article-id><article-id pub-id-type="publisher-id">210022</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Maturation and growth of renal function: Dosing renally cleared drugs in children</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Hayton</surname><given-names initials="WL">William L.</given-names></name><address><phone>(614) 292-1288</phone><fax>(614)292-7766</fax><email>hayton.1@osu.edu</email></address><xref ref-type="aff" rid="Aff1"/></contrib><aff id="Aff1">Division of Pharmaceutics, College of Pharmacy, The Ohio State University, 500 West 12th Ave., 43210-1291 Columbus, OH </aff></contrib-group><pub-date pub-type="collection"><month>3</month><year>2000</year></pub-date><pub-date pub-type="epub"><day>3</day><month>3</month><year>2000</year></pub-date><volume>2</volume><issue>1</issue><issue-id pub-id-type="pmc-issue-id">181860</issue-id><fpage>22</fpage><lpage>28</lpage><history><date date-type="received"><day>6</day><month>9</month><year>1999</year></date><date date-type="accepted"><day>15</day><month>2</month><year>2000</year></date></history><pub-history><event event-type="pmc-release"><date><day>03</day><month>03</month><year>2000</year></date></event><event event-type="pmc-live"><date><day>14</day><month>10</month><year>2009</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-04-17 04:25:13.220"><day>17</day><month>04</month><year>2024</year></date></event></pub-history><permissions><copyright-statement>&#169; American Association of Pharmaceutical Scientists 2000</copyright-statement></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="12248_2008_Article_210022.pdf"/><abstract xml:lang="en"><p>A model was developed that characterized the maturation and growth of the renal function parameters (RFPs) glomerular filtration rate (GF), active tubular secretion (AS), and renal plasma flow (Q<sub>R</sub>). Published RFP values were obtained from 63 healthy children between the ages of 2 days and 12 years. Maturation over time was assumed to be exponential from an immature (RFP<sub>im</sub>) to a mature (RFP<sub>ma</sub>) level; for growth, RFP<sub>im</sub> and RFP<sub>ma</sub> were assumed to follow the allometric equation: RFP(age, W)=aW<sup>b</sup>e<sup>&#8722;kmat</sup><sup>*</sup>age+cW<sup>b</sup>(1&#8722;e<sup>&#8722;kmat</sup><sup>*</sup>age), where W is body weight, k<sub>mat</sub> is the maturation rate constant, b is the body weight exponent, and a and c are RFP<sub>im</sub> and RFP<sub>ma</sub> at unit W. The model-based equation was fitted to the age-W, RFP values by a nonlinear least-squares method. For GF, the maturation half-life was 7.9 months (90% maturation, 26 months), the body weight exponent was 0.662, and the ratio c/a (which reflected the magnitude of the maturation influence) was 3.1. For AS and Q<sub>R</sub>, the maturation half-lives were about 3.8 months and the ratio c/a was about 1.8. For renally eliminated drugs, the model can be used to estimate dosing regimens that are based on the adult dosing regimen and the age and weight of the child.</p></abstract><kwd-group><title>KeyWords</title><kwd>Renal Function</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#169; American Association of Pharmaceutical Scientists 2000</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>